What are the most common causes of hypomagnesemia in the elderly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Causes of Hypomagnesemia in the Elderly

The most common causes of hypomagnesemia in elderly patients are medication-related factors (particularly diuretics, proton pump inhibitors, and certain antibiotics), poor nutritional intake, and chronic medical conditions affecting magnesium homeostasis. 1

Medication-Related Causes

Diuretics

  • Thiazide diuretics: Inhibit sodium chloride cotransporter in the distal convoluted tubule, causing hypokalemia, metabolic alkalosis, renal magnesium wasting, and hypocalciuria 2
  • Loop diuretics: Inhibit sodium chloride transport in the ascending loop of Henle, leading to hypokalemia, metabolic alkalosis, renal magnesium wasting, and hypercalciuria 2
  • Diuretic use is strongly associated with hypomagnesemia in elderly patients with heart failure 3

Proton Pump Inhibitors (PPIs)

  • Long-term PPI use significantly increases risk of hypomagnesemia (PR 1.80; 95%CI 1.20-2.72) 4
  • PPIs impair intestinal magnesium absorption through effects on TRPM6/7 channels

Other Medications

  • Antibiotics: Certain antibiotics (aminoglycosides, amphotericin B) can cause renal magnesium wasting
  • Chemotherapeutic agents: Cisplatin and cetuximab are particularly associated with magnesium loss 1
  • Immunosuppressants: Calcineurin inhibitors (cyclosporine, tacrolimus) can cause hypomagnesemia
  • Antidiabetic medications: Metformin significantly increases risk (PR 2.34; 95%CI 1.56-3.50) 4
  • Other medications associated with hypomagnesemia in elderly:
    • Calcium supplements (PR 2.26) 4
    • Insulin (PR 3.88) 4
    • Vitamin K antagonists (PR 2.01) 4
    • Statins (PR 2.44) 4
    • Bisphosphonates (PR 2.97) 4
    • Selective beta blockers (PR 2.01) 4

Polypharmacy

  • The number of different drugs used is inversely associated with magnesium levels 4
  • Polypharmacy (≥5 medications) significantly increases risk of hypomagnesemia (PR 1.81; 95%CI 1.08-3.14) 4
  • 67.6% of geriatric outpatients use ≥5 medications 4

Medical Conditions

Gastrointestinal Disorders

  • Malabsorption syndromes: Celiac disease, inflammatory bowel disease, short bowel syndrome
  • Chronic diarrhea: Leads to significant magnesium loss
  • Alcoholism: Common in elderly, causes both decreased intake and increased renal excretion

Endocrine Disorders

  • Diabetes mellitus: Associated with increased renal magnesium excretion
  • Hyperparathyroidism: Affects magnesium homeostasis
  • Hyperthyroidism: Increases renal magnesium excretion

Renal Disorders

  • Chronic kidney disease: Impairs magnesium conservation
  • Tubular disorders: Bartter syndrome, Gitelman syndrome (though these are usually diagnosed earlier in life)

Nutritional Factors

  • Poor dietary intake: Common in elderly due to decreased appetite, chewing difficulties, social isolation
  • Malnutrition: Prevalent in hospitalized and institutionalized elderly
  • Alcohol abuse: Decreases dietary magnesium intake and intestinal absorption

Clinical Implications

Hypomagnesemia in elderly patients is associated with:

  • Increased risk of cardiac arrhythmias and sudden cardiac death 3
  • Worsening of heart failure symptoms
  • Neuromuscular symptoms (tremor, tetany, seizures)
  • Increased risk of delirium and confusion 3
  • Potentiation of digoxin toxicity 3
  • Resistance to potassium repletion in hypokalemia

Monitoring Considerations

  • Regular monitoring of magnesium levels is essential in elderly patients with:

    • Heart failure on diuretic therapy
    • Long-term PPI use
    • Polypharmacy
    • Chronic kidney disease
    • Diabetes mellitus
    • Malnutrition risk
  • Target serum magnesium level should be >0.74 mmol/L (>1.8 mg/dL) 1, 2

Prevention Strategies

  • Medication review to identify and minimize drugs causing magnesium depletion
  • Adequate dietary magnesium intake (green vegetables, nuts, whole grains)
  • Magnesium supplementation for high-risk patients
  • Treatment of underlying conditions affecting magnesium homeostasis

Understanding these common causes of hypomagnesemia in elderly patients is essential for appropriate prevention, monitoring, and management strategies to reduce associated morbidity and mortality.

References

Guideline

Hypomagnesemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hypomagnesemia: an evidence-based approach to clinical cases.

Iranian journal of kidney diseases, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.